U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880561) titled 'AI-Driven Digital Therapeutic for Insomnia: Development and Clinical Validation' on Oct. 12.
Brief Summary: Insomnia is a prevalent global health problem, with approximately one in five Taiwanese adults chronically affected. Prolonged use of sedative-hypnotic medications carries risks of adverse effects, dependence, and unnecessary healthcare utilization. Although cognitive behavioral therapy for insomnia (CBT-I) is internationally recommended as first-line treatment, workforce shortages and suboptimal patient adherence limit its reach. This project will develop an artificial intelligence-driven mobile application for insomnia that ...